Supreme Court wants cap on trade margin for all essential medicines and medical products
Government proposes 30% trade-margin cap on patented and non-patented cancer medicines, but top court asks why a margin cap cannot be extended to all medicines and medical products; the court says the government has to ensure that DPCO-approved medicines, whose price is legally regulated, reach patients
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.thehindu.com — the content belongs to The Hindu - Sci-Tech.
